Skip to main content

Advertisement

Log in

Development and Validation of a RP-HPLC Method for the Determination of Zidovudine and Its Related Substances in Sustained-release Tablets

  • Original Papers
  • Published:
Analytical Sciences Aims and scope Submit manuscript

Abstract

A reversed-phase high-performance liquid chromatography (RP-HPLC) method for the rapid and accurate quantification of zidovudine (AZT) in sustained release tablets during stability testing was developed. A Waters RP-18 XTerraTM® column, using a water:methanol (80:20, v/v%) mobile phase at a flow rate of 1.0 ml min−1, and UV detection at 266 nm, was employed. The method of validation parameters indicate a linear range of between 40.0 to 220.0 μg ml−1 with an LOQ of 1.985 μg ml−1 and an LOD of 0.655 μg ml−1 for the analyte. The degradation products of AZT were isolated and characterized for the first time. There was a very little decline of antiviral by heat, and AZT did not completely degrade either by acid or alkaline hydrolysis. On the other hand, oxidation caused a higher degradation stress in the drug. Finally, the degradation products resulting from stress studies were not found to interfere with the detection of antiviral, which is an advantage of the presently proposed method.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. N. A. Ochekpe, N. C. Ngwuluka, H. Owolayo, and T. Fashedemi, Diss. Tecnol., 2006, November, 12.

  2. G. Ramachandran, A. K. Hemanthkumar, V. Kumaraswami, and S. J. Swaminathan, J. Chromatogr., B, 2006, 843, 339.

    Article  CAS  Google Scholar 

  3. M. A. Quevedo, S. R. Ribone, G. N. Moroni, and M. C. Briñón, Bioorg. Med. Chem., 2008, 16, 2779.

    Article  CAS  Google Scholar 

  4. C. H. R. Serra, E. E. M. Koono, E. K. Kano, S. G. Schramm, Y. P. Armando, and V. Porta, Clin. Ther., 2008, 30, 902.

    Article  CAS  Google Scholar 

  5. B. Uslu and S. A. Özkan, Anal. Chim. Acta, 2002, 466, 175.

    Article  CAS  Google Scholar 

  6. The United States Pharmacopeia, USP 31/NF 26, 2008, ed. Rockville, United States Pharmacopeia Convention, Inc., MD, 3553.

  7. A. Kuksal, A. K. Tiwary, N. K. Jain, and S. Jain, AAPS PharmSciTech., 2006, 7, E1–E9.

  8. M. Pendela, E. Van Gyseghem, G. Van den Mooter, L. Baert, J. Rosier, J. Hoogmartens, and E. Adams, J. Pharm. Biomed. Anal., 2009, 49, 508.

    Article  CAS  Google Scholar 

  9. Eurachem Working Group, The Fitness for Purpose of Analytical Methods: A Laboratory Guide to Method Validation and Related Topics, 1998, http://www.eurachem.org/guides/pdf/valid.pdf.

  10. FDA (Food and Drug Administration), Guidance for Industry: Analytical Procedures and Methods Validation, Center for Drug Evaluation and Research, 2000, http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm122858.pdf.

  11. ICH Q2(R1), Validation of Analytical Procedures: Text and Methodology, International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, 2005, http://www.ich.org/LOB/media/MEDIA417.pdf.

  12. NATA Technical Note 17, Guidelines for the Validation and Verification of Chemical Test Methods, 2009, http://www.nata.com.au/publications/category/9-nata-technical-notes.

  13. J. Ermer, J. Pharm. Biomed. Anal., 2001, 24, 755.

    Article  CAS  Google Scholar 

  14. J. Ermer and H. J. Ploss, J. Pharm. Biomed. Anal., 2005, 37, 859.

    Article  CAS  Google Scholar 

  15. Ph. Hubert, J. J. Nguyen-Huu, B. Boulanger, E. Chapuzet, P. Chiap, N. Cohen, P. A. Compagnon, W. Dewé, M. Feinberg, M. Lallier, M. Laurentie, N. Mercier, G. Muzard, C. Nivet, L. Valat, and E. Rozet, J. Pharm. Biomed. Anal., 2007, 45, 70.

    Article  CAS  Google Scholar 

  16. Ph. Hubert, J. J. Nguyen-Huu, B. Boulanger, E. Chapuzet, N. Cohen, P. A. Compagnon, W. Dewé, M. Feinberg, M. Laurentie, N. Mercier, G. Muzard, L. Valat, and E. Rozet, J. Pharm. Biomed. Anal., 2007, 45, 82.

    Article  CAS  Google Scholar 

  17. M. Bakshi and S. Saranjit, J. Pharm. Biomed. Anal., 2002, 28, 1011.

    Article  CAS  Google Scholar 

  18. ICH Q1A(R2), Stability Testing of New Drug Substances and Products, International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, 2003, http://www.ich.org/LOB/media/MEDIA419.pdf.

  19. ICH Q1B, Stability Testing: Photostability Testing of New Drug Substances and Products, International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, 2005, http://www.ich.org/LOB/media/MEDIA412.pdf.

  20. K. C. Waterman and R. C. Adami, Int. J. Pharm., 2005, 293, 101.

    Article  CAS  Google Scholar 

  21. W. Aman and K. Thoma, Int. J. Pharm., 2002, 243, 33.

    Article  CAS  Google Scholar 

  22. L. Maggi, E. O. Machiste, E. Fasani, A. Albini, L. Segale, and U. Conte, Eur. J. Pharm. Biopharm., 2003, 55, 99.

    Article  CAS  Google Scholar 

  23. J. Karpińska, A. Sokól, and M. Skoczyla, Spectrochim. Acta, Part A, 2008, 71, 1562.

    Article  Google Scholar 

  24. SPSS Statistics for Windows Ver. 16.0, Statistical Software, Inc., 2007.

  25. A. Dunge, A. K. Chakraborti, and S. Singh, J. Pharm. Biomed. Anal., 2004, 35, 965.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Eugénia Pina.

Rights and permissions

Reprints and permissions

About this article

Cite this article

dos Santos, J.V., de Carvalho, L.A.E.B. & Pina, M.E. Development and Validation of a RP-HPLC Method for the Determination of Zidovudine and Its Related Substances in Sustained-release Tablets. ANAL. SCI. 27, 283–289 (2011). https://doi.org/10.2116/analsci.27.283

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2116/analsci.27.283

Navigation